Y-Intercept (HK)’s LENZ Therapeutics LENZ Stock Holding History

Y-Intercept (HK)’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$402K	Sell	70,728 -87,987	-55%	-$709K	0.01%	1373
2026 Q1	$1.45M	Buy	158,715 +118,100	+291%	+$1.66M	0.03%	872
2025 Q4	$650K	Buy	+40,615	New	+$1.18M	0.01%	1149

Other funds holding LENZ

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

AFC

Ares Financial Consulting Calabasas, California $139M AUM

Y-Intercept (HK)'s LENZ Position: Q2 2026 in Review

Y-Intercept (HK) reduced its LENZ Therapeutics (LENZ) stake by 55% in Q2 2026, selling an estimated $709K and leaving 70,728 shares worth $402K. The position accounts for 0.01% of the portfolio, ranked #1373.

Y-Intercept (HK) first reported a position in LENZ in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.45M in Q1 2026. 6 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

Y-Intercept (HK) held 70,728 shares of LENZ Therapeutics worth $402K as of Q2 2026.
Y-Intercept (HK) sold 87,987 LENZ Therapeutics shares in Q2 2026, an estimated $709K.
LENZ Therapeutics made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1373 holding.
Y-Intercept (HK) first reported a position in LENZ Therapeutics in Q4 2025 and has held it in 3 quarters since.
Y-Intercept (HK)'s LENZ Therapeutics position peaked at $1.45M in Q1 2026.
6 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.